EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Health Issues HCR

Regulatory policies related to health reform legislation: structure, drug benefits, disclosure Regulatory implementation of HITECH/Accounting of Disclosures Issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs).

Contacted: White House Office; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Congressional Budget Office (CBO); Office of Personnel Management (OPM); Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Labor, Dept of (DOL); SENATE; Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA)

Postal POS

Postal Reform proposals and their impact on 6 day mail delivery

Contacted: Government Accountability Office (GAO); SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); White House Office; Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Federal Trade Commission (FTC); Food & Drug Administration (FDA); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Office of Personnel Management (OPM)

Defense DEF

Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill

Contacted: Internal Revenue Service (IRS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); SENATE; Medicare Payment Advisory Commission (MedPAC); Labor, Dept of (DOL); Congressional Budget Office (CBO); Office of Personnel Management (OPM); White House Office

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General reg/leg Part D issues such as direct negotiation (budget proposals). Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors' prompt pay discounts from the definition of Average Sales Price. Medicare audit and preferred network restrictions. S. 867, Medicare Prescription Drug Integrity andAnd Transparency Act of 2013. General issues regarding combatting Rx abuse in Medicare and Medicaid (pharmacy lock-in, etc)

Contacted: Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Office of Personnel Management (OPM); Food & Drug Administration (FDA); White House Office; Medicare Payment Advisory Commission (MedPAC); SENATE; Executive Office of the President (EOP); Congressional Budget Office (CBO); Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Government Accountability Office (GAO)

Bills named: S. 867 (113th)

Pharmacy PHA

Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.

Contacted: Congressional Budget Office (CBO); Medicare Payment Advisory Commission (MedPAC); Federal Trade Commission (FTC); Government Accountability Office (GAO); SENATE; Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); White House Office; Office of Personnel Management (OPM); Food & Drug Administration (FDA)

Bills named: H.R. 1367 (113th), S. 867 (113th)

Taxation/Internal Revenue Code TAX

Regulatory implementation of various tax provisions in the health reform legislation

Contacted: Food & Drug Administration (FDA); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); White House Office; Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Federal Trade Commission (FTC); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Congressional Budget Office (CBO); SENATE; Labor, Dept of (DOL); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS)

Labor Issues/Antitrust/Workplace LBR

Legislation to exempt certain pharmacies from the antitrust laws for purposes of negotiating with payers (HR 1188)

Contacted: Executive Office of the President (EOP); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); Federal Trade Commission (FTC); Medicare Payment Advisory Commission (MedPAC); White House Office; Labor, Dept of (DOL); Food & Drug Administration (FDA); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS)

Bills named: H.R. 1188 (113th)